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Abstract
Background. Social cognition has been associated with functional outcome in patients with
first episode psychosis (FEP). Social cognition has also been associated with neurocognition
and cognitive reserve. Although cognitive reserve, neurocognitive functioning, social cogni-
tion, and functional outcome are related, the direction of their associations is not clear.
Therefore, the main aim of this study was to analyze the influence of social cognition as a
mediator between cognitive reserve and cognitive domains on functioning in FEP both at
baseline and at 2 years.
Methods. The sample of the study was composed of 282 FEP patients followed up for 2 years.
To analyze whether social cognition mediates the influence of cognitive reserve and cognitive
domains on functioning, a path analysis was performed. The statistical significance of any
mediation effects was evaluated by bootstrap analysis.
Results. At baseline, as neither cognitive reserve nor the cognitive domains studied were
related to functioning, the conditions for mediation were not satisfied. Nevertheless, at 2
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years of follow-up, social cognition acted as a mediator between cognitive reserve and func-
tioning. Likewise, social cognition was a mediator between verbal memory and functional out-
come. The results of the bootstrap analysis confirmed these significant mediations (95%
bootstrapped CI (−10.215 to −0.337) and (−4.731 to −0.605) respectively).
Conclusions. Cognitive reserve and neurocognition are related to functioning, and social cog-
nition mediates in this relationship.
Introduction
Neurocognition, cognitive reserve, and social cognition have all
been related to functioning in first-episode psychosis (FEP).
Specifically, numerous studies have found that cognitive deficits
are present early in psychosis, manifesting in multiple cognitive
domains including working memory, executive function, atten-
tion, processing speed, and/or learning and memory (Zabala
et al., 2010; González-Ortega et al., 2013; Bora and Murray,
2014). These deficits have been related to poorer psychosocial
functioning (Leeson et al., 2011; González-Ortega et al., 2013;
Green and Harvey, 2014; Torgalsbøen et al., 2015), but some stud-
ies have not found this association (Kravariti et al., 2003; Stirling
et al., 2003). Overall, there is a lack of consensus on how cognitive
functioning changes over the course of the disease and its relation
to functional outcome.
Cognitive reserve has been associated with the functional
course of FEP, patients with a higher cognitive reserve showing
a better outcome (Leeson et al., 2011; Amoretti et al., 2016).
Cognitive reserve has been defined as the ability of a brain to
cope with brain pathology and thereby minimize symptoms
(Stern, 2002) and variables used as measures of cognitive reserve
include premorbid IQ, educational level, and occupational attain-
ment (Anaya et al., 2016).
Social cognition has also been associated with functional out-
come. Indeed, it has been suggested that social cognition is a bet-
ter predictor of functional outcome of FEP patients than
neurocognition (Fett et al., 2011; Ohmuro et al., 2016). Social cog-
nition includes theory of mind, social perception, social knowl-
edge, attributional biases, and emotion processing, areas that are
affected in FEP patients (Horan et al., 2012; Bora and Pantelis,
2013; Bliksted et al., 2014). It has also been associated with neu-
rocognition and premorbid IQ (Bliksted et al., 2014) and there is
evidence of a relationship between social cognition and neurocog-
nition and that this may have a negative influence on functional
outcome of FEP (Schmidt et al., 2011).
Although cognitive reserve, neurocognitive functioning, social
cognition, and functional outcome are probably related, the direc-
tion of their associations is not clear (Fett et al., 2011; Schmidt
et al., 2011; Pinkham and Harvey, 2012; Hedman et al., 2013;
Lin et al., 2013). In a systematic review, Schmidt et al. (2011)
found that social cognition acts as a mediator between neurocog-
nition and functioning in schizophrenia (Schmidt et al., 2011),
though in individuals at clinical high risk of psychosis this was
not observed (Barbato et al., 2013).
Therefore, for predicting the outcome of FEP patients after the
onset of the disease, it is important to explore the potential medi-
ating role of social cognition in the association between neurocog-
nition and functioning. In this context, our study had the following
objectives: (1) to assess changes from baseline in cognitive function-
ing, social cognition, and functioning at 2 years of follow-up in FEP
patients; (2) to analyze the influence of cognitive reserve and cog-
nitive domains on social cognition and functioning at baseline
and at 2 years of follow-up; (3) to analyze the influence of social
cognition on functioning; and (4) to analyze the influence of social




This work was part of the ‘Phenotype-genotype and environmen-
tal interaction. Application of a predictive model in first psychotic
episodes’ study (PEPs study, from its acronym in Spanish)
(Bernardo et al., 2013).
Patients were aged between 18 and 35 years old at the time of
first evaluation and were required to have fluent Spanish and to
give written informed consent. If patients were not capable of giv-
ing consent or minors, a legally authorized representative was
asked to provide consent on their behalf. Moreover, it was
required that patients had a less than 12-month history of psych-
otic symptoms.
Exclusion criteria for patients were: mental retardation accord-
ing to the DSM-IV (American Psychiatric Association, 1994)
(including not only an IQ below 70, as determined using the
test described in Table 1, but also poor functioning), history of
head trauma with the loss of consciousness, and organic illness
affecting mental health. The study was approved by the clinical
research ethics committees of all participating centers in the
PEPs Group.
Initially, 335 FEP patients were included in the study. Of these,
53 patients were excluded for not having seven or more neuro-
psychological tests completed. Thus, the final study sample con-
sisted of 282 patients.
Data collection
Sociodemographic and clinical data were collected at baseline and
at 2 years, while cognitive assessment was performed at 2 months
of follow-up, in order to ensure the psychopathological stability of
patients, and at 2 years of follow-up. If patients were actively
psychotic at the time of the 2-year follow-up, we delayed the
assessment until their condition was stabilized. The assessment
protocol was fully described by Bernardo et al. (2013).
Adult patients were diagnosed with FEP using the Structured
Clinical Interview for DSM-IV Axis I and II Disorders (First
et al., 1997), while the Schedule for Affective Disorders and
Schizophrenia for school-age children-Present and Lifetime ver-
sion (Kaufman et al., 1997) was used for those under 18 years
old, following DSM-IV criteria.
Functional impairment of patients was evaluated using the
functional assessment short test (FAST) (Rosa et al., 2007), for
which high scores suggest poorer functioning. The FAST is a
measure of functioning that is valid, reliable, and sensitive to
change and has been validated and widely used in bipolar
Psychological Medicine 2703
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291719002794
Downloaded from https://www.cambridge.org/core. Universidad de Zaragoza, on 19 Feb 2021 at 14:03:30, subject to the Cambridge Core terms of use, available at
disorder (Rosa et al., 2011; Bonnín et al., 2018; Vieta et al., 2018),
attention-deficit hyperactivity disorder (Rotger et al., 2014), and
FEP (González-Ortega et al., 2010).
The substance use was assessed using the European Adaptation
of a Multidimensional Assessment Instrument for Drug and
Alcohol Dependence (EuropASI) and patients were categorized
according to EuropASI scores into four groups (no use, use,
abuse, and dependence) (Kokkevi and Hartgers, 1995).
The following cognitive domains are assessed: processing
speed, attention, verbal memory, working memory executive
function, and premorbid IQ. The tests and measures used for
domain summary scores are described by Bernardo et al. (2013)
and Cuesta et al. (2015) (Table 1).
Estimated premorbid IQ, educational level, and occupational
attainment were used as measures of cognitive reserve (Anaya
et al., 2016). IQ was evaluated with the Vocabulary subtest of
Wechsler Adult Intelligence Scale (Wechsler, 1997) or Wechsler
Intelligence Scale for Children-IV (Wechsler, 2003), while educa-
tional level and occupational attainment variables were assessed
with the Hollingshead–Redlich Scale (Hollingshead and Redlich,
1958).
Social cognition was assessed with understanding emotions,
managing emotions, and total emotional intelligence scores of
the Mayer–Salovey–Caruso Emotional Intelligence Test, which
rate the helpfulness of certain moods and assess the effectiveness
of strategies to manage emotions (Mayer et al., 2009).
Statistical analyses
Demographic variables are described with means (±S.D.) and per-
centages. t Tests for paired samples were used to analyze
differences in cognitive performance and functioning of patients
between baseline and 2 years of follow-up.
To assess the cognitive domains, we calculated the average of
the z-scores of the neuropsychological variables which corres-
pond to each domain (Table 1). As the scores of the Trail
Making Test (Reitan and Wolfson, 1985) are inverse, they
were multiplied by −1 to facilitate the interpretation (higher
scores indicating better performance). The same approach was
taken for cognitive reserve, that is, averages of the z-scores
were calculated for estimated premorbid IQ, educational level,
and occupational attainment.
To explore whether social cognition mediates the influence of
cognitive reserve and cognitive domains on functioning, a three-
step procedure was used (Frazier et al., 2004). Figure 1 represents
the hypothesized mediation model. Firstly, we analyzed the rela-
tionship between cognitive reserve and cognitive domains with
social cognition with a linear regression (path a). Secondly, linear
regression models were built to explore the association of cognitive
reserve and cognitive domains (independent variables) with func-
tioning (dependent variable) (path c). All models were adjusted
for potential confounders (namely, age, sex, civil status, socio-
economic level, educational level, diagnosis, substance use, and
family history) with a stepwise procedure which only included vari-
ables in the final model if they produced a significant change in the
coefficient of the independent variable. Finally, social cognition was
included as a mediator in the multiple regressions found to be sig-
nificant in the second step (paths b and c´). If the relation of social
cognition with functioning was significant and the path c associ-
ation became non-significant, conditions for mediation would be
satisfied, this suggesting that social cognition is a mediating vari-
able. The statistical significance of the mediation was examined
by bootstrap analysis (95% bootstrapped confidence interval (CI)).
Data analyses were conducted with Stata 12.1. The level of sig-
nificance was set at p < 0.05, except for the analyses of the cogni-
tion domains for which we applied the Bonferroni correction for
multiple comparisons. For these, the level of significance was set
at p < 0.01, calculated by dividing 0.05 by five, the number of cog-
nitive domains.
Results
Sociodemographic characteristics, cognitive, and functional
course of the sample
Baseline characteristics of the sample are summarized in Table 2.
The total sample comprised 192 men (68.1%) with a mean age of




Premorbid IQ Vocabulary subtest of WAIS-IIIa/WISC-IVb
Processing speed Trail Making Testc-form A
Stroop Test word and color conditiond
Attention CPT-IIe
Verbal memory TAVECf
Working memory Digit Span subtest of the WAIS-IIIa/WISC-IVb






Trail Making Testc-form B
WCSTi
Stroop Testd-interference condition
aWechsler Adult Intelligence Scale III (WAIS-III) (Wechsler, 1997).
bWechsler Intelligence Scale for Children-IV (WISC-IV) (Wechsler, 2003).
cTrail Making Test (Reitan and Wolfson, 1985).
dStroop Test (Golden, 1978).
eConners’ Continuous Performance Test (CPT-II) (Conners, 2004).
fTest de Aprendizaje Verbal España-Complutense (TAVEC) (Benedet and Alejandre, 1998).
gControlled Oral Word Association Test (FAS test) (Loonstra et al., 2001).
hAnimal words (Peña-Casanova, 1990).
iWisconsin Card Sorting Test (WCST) (Heaton et al., 1993).
Fig. 1. Hypothesized mediation model.
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23.64 (5.93) years. Of these, 123 (43.6%) had a diagnosis of
schizophrenia and 59 (20.9%) had a diagnosis of bipolar disorder.
The drug most frequently used was tobacco (66.4%) and most
patients were single (86.9%).
During 2 years of follow-up, all the cognitive domain scores
improved significantly, except working memory and executive
function. Social cognition, cognitive reserve, and functioning
were also significantly better at 2 years (Table 3).
Correlations between cognitive and functional variables are
presented in a Supplementary Table.
Relationship between cognitive reserve, social cognition,
general cognition, and functioning
Table 4 reports the results of the analysis of the basic path models
at both baseline and 2 years. At baseline, cognitive reserve was sig-
nificantly associated with social cognition. Regarding baseline
cognitive domain scores, after the Bonferroni correction, only
processing speed and verbal memory showed a significant associ-
ation with social cognition at baseline (path a). Social cognition
was not significantly associated with functioning at baseline
(path b). Neither cognitive reserve nor the cognitive domains
were related to functioning at baseline (path c).
At 2 years of follow-up, in addition to baseline cognitive
reserve and verbal memory, baseline executive function was also
associated with social cognition at 2 years, while processing
speed became non-significant at this time point (path a).
Furthermore, social cognition at both baseline and 2 years was
significantly associated with functioning at the end of the
follow-up (path b). Cognitive reserve was significantly related to
functioning at 2 years. Regarding baseline cognitive domain
scores, after applying the Bonferroni correction, only attention
and verbal memory were significantly related to functioning at
2 years (path c).
The influence of social cognition as a mediator between
cognitive reserve and cognitive domains on functioning
At baseline, as neither cognitive reserve nor cognitive domain
scores were related to functioning (path c), the conditions for
mediation were not satisfied.
At 2 years of follow-up, after including social cognition at
baseline in the final model, all significant relations of baseline
cognitive domains and cognitive reserve with FAST at 2 years
remained significant. Further, their coefficients increased after
the inclusion of social cognition, and therefore, baseline social
cognition did not mediate in these relations. Nevertheless, rele-
vant results were obtained after including social cognition at 2
years in the model. Social cognition at 2 years was a significant
mediator between cognitive reserve and functioning at 2 years
(Fig. 2). In fact, its association with functioning was significant
(path b), while the relation between cognitive reserve and func-
tioning became non-significant (path c´). These findings suggest
a significant full mediation of social cognition, it mediating 20.8%
of the effect (95% bootstrapped CI −10.215 to −0.337).
With respect to cognitive domains, after including social cog-
nition at 2 years in the regression model between baseline atten-
tion and functioning at 2 years, social cognition had a significant
association with functioning (path b) and attention remained sig-
nificant, its coefficient increasing (b = 3.445, p = 0.006). Therefore,
the conditions for the mediation of social cognition were not sat-
isfied. Regarding baseline verbal memory, this domain lost its sig-
nificant association with functioning at 2 years when including
social cognition at 2 years in the model (path c´), while the latter
had a significant association with functioning (path b) (Fig. 3).
Thus, social cognition at 2 years appears to be a significant full
mediator, it mediating 25.2% of the effect (95% bootstrapped
CI −4.731 to −0.605).
Discussion
The main finding of this study is that social cognition acted as a
mediator between cognitive reserve and functioning at 2 years of
follow-up. Likewise, social cognition was a mediator between ver-
bal memory and functional outcome. These findings suggest that
social cognition is involved and indeed plays a crucial role in the
functional outcome of FEP patients. There is little previous
research on this mediation, although in a systematic review
Schmidt et al. (2011) also found that social cognition mediated
the relationship between neurocognition and functioning in
schizophrenia. Our findings are from a sample of patients with
FEP and take into account the role of cognitive reserve.
Moreover, our study has a longitudinal design.
There is extensive evidence of social cognitive deficits in FEP
(Horan et al., 2012; Bora and Pantelis, 2013; Bliksted et al.,
Table 2. Baseline characteristics of the sample
Variable Total sample (n = 282)
Sex
Male 192 (68.1%)









Table 3. Means of cognition and FAST during follow-up (n = 186)
Variable Baseline 2 years
Attention −0.38 (0.99) −0.21 (0.87)
Processing speed −0.96 (1.06) −0.69 (1.00)
Verbal memory −1.07 (1.24) −0.65 (1.11)
Working memory −0.71 (0.76) −0.67 (0.86)
Executive function −0.43 (0.50) −0.16 (0.62)
Social cognition −0.72 (0.89) −0.58 (0.95)
Cognitive reserve −0.45 (0.56) 0.04 (0.56)
FAST 26.01 (16.16) 19.40 (15.40)
p value <0.05 except for the cognitive domains for which the Bonferroni correction was
applied ( p < 0.01). Bold values represent the significant values.
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2014; Langdon et al., 2014; Ho et al., 2015) and related conditions
(Lahera et al., 2015; Varo et al., 2017). Impairments in social
functioning have been related to deficits in emotion recognition,
emotional intelligence/social perception, and social knowledge
of FEP patients (Addington et al., 2010), because of their difficul-
ties managing specific situations and predicting social conse-
quences, as well as in recognizing changes in behavioral
meaning (Montreuil et al., 2010). Moreover, it is considered
that deterioration in social cognition has been related to poor
functioning, especially poor work and social functioning as well
as interpersonal and problem solving skills (Addington et al.,
2010; Fett et al., 2011; Horan et al., 2012).
A second major finding of our study is that social cognition
may be a potential marker for predicting the functional outcome
of patients. Previous studies have also found that social cognition
may be a trait marker of psychosis (Bora et al., 2008; Bora and
Pantelis, 2013). In fact, it has been seen that social cognition
could be a better predictor of functional outcome than neurocog-
nition with a significant impact on general functioning of patients
(Fett et al., 2011; Ohmuro et al., 2016). In our sample of FEP
patients, although baseline social cognition was related to func-
tioning at 2 years, it was not a mediator between cognition and
functional outcome; however, social cognition 2 years later was
a significant mediator. This finding is probably related to the
state and trait nature of social cognition. Social dysfunction has
been described as a state marker related to symptoms of schizo-
phrenia, and some studies suggest that it is not impaired after
symptom recovery (Corcoran et al., 1995; Drury et al., 1998).
Nonetheless, several studies have demonstrated deficits in social
cognition in remitted patients (Herold et al., 2002; Janssen
et al., 2003; Inoue et al., 2006). It is possible that patients have
social cognition deficits as a trait marker, and in addition, these
deficits may worsen with symptoms, indicating that it is both a
trait and a state variable. Moreover, social cognitive deficits are
Table 4. Statistical analyses of the paths a and b
Path a (cognitive domains/CR at baseline→ social cognition) Social cognition at baseline Social cognition at 2 years
Cognitive reserve b = 0.462, p < 0.001 b = 0.491, p < 0.001
Attention b =−0.016, p = 0.461 b = 0.057, p = 0.463
Processing speed b = 0.159, p = 0.004 b = 0.138, p = 0.051
Verbal memory b = 0.148, p = 0.002 b = 0.185, p = 0.003
Working memory b = 0.146, p = 0.051 b = 0.206, p = 0.039
Executive function b = 0.420, p = 0.059 b = 0.910, p = 0.006
Path b (social cognition→ FAST) FAST at baseline FAST at 2 years
Social cognition at baseline b =−1.862, p = 0.077 b =−3.410, p = 0.006
Social cognition at 2 years – b =−3.347, p = 0.007
Path c (cognitive domains/CR at baseline→ FAST) FAST at baseline FAST at 2 years
Cognitive reserve b =−2.105, p = 0.195 b =−3.849, p = 0.048
Attention b = 0.125, p = 0.725 b = 3.257, p = 0.005
Processing speed b =−1.347, p = 0.125 b =−0.961, p = 0.364
Verbal memory b =−1.459, p = 0.059 b =−2.451, p = 0.007
Working memory b =−2.881, p = 0.014 b =−2.062, p = 0.162
Executive function b =−6.669, p = 0.057 b =−9.594, p = 0.016
p value <0.05 except for the cognitive domains for which the Bonferroni correction was applied ( p < 0.01). Bold values represent the significant values.
Fig. 2. Mediation of social cognition between cognitive reserve and functioning at 2
years.
Fig. 3. Mediation of social cognition between verbal memory and functioning at 2
years.
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already present even in patients at risk of psychosis (Thompson
et al., 2012; Ohmuro et al., 2016; Zhang et al., 2016) and deficits
have even been found in unaffected first-degree relatives (Bora
and Pantelis, 2013), this highlighting its trait properties.
On the other hand, another relevant finding of our study is
that cognitive reserve and neurocognition predicted social cogni-
tion, both at baseline and 2 years. Bliksted et al. (2014) also found
a correlation between social cognition and IQ, though they distin-
guish between a complex version of social cognitive deficits linked
with IQ and another version related to simpler forms of social
cognition that are independent of IQ. Regarding cognitive
domains, processing speed and verbal memory showed a signifi-
cant association with social cognition at baseline. At 2 years of
follow-up, verbal memory and executive function were associated
with social cognition. Previous studies have also found that cog-
nitive functioning is related to social cognition. Theory of mind
disabilities have been related to general cognitive impairment
(Bora et al., 2008) and more specifically, Fernandez-Gonzalo
et al. (2013, 2014) showed that executive function was related to
theory of mind in FEP patients. Further, Sachs et al. (2004)
found a correlation between emotion discrimination and verbal
memory and language processing cognitive domains.
As we hypothesized, at 2 years of follow-up there was an
improvement in social cognition, cognitive functioning, and gen-
eral functioning of patients. There is extensive evidence of the
involvement of cognitive impairment in the functional outcome
of FEP patients (Lepage et al., 2014; Torgalsbøen et al., 2015).
Neurocognitive deficits have been identified as a core symptom
of schizophrenia and may be more related to functional recovery
of patients than clinical symptoms (Lepage et al., 2014). It has
been suggested that cognitive impairment appears soon after or
even before the first episode of psychosis (Bora and Murray,
2014), and while some studies argue that there is deterioration
in cognitive functions in the follow-up (Morrison et al., 2006;
Arango et al., 2012), others postulate an improvement in cognitive
function (Rodríguez-Sánchez et al., 2008; Becker et al., 2010). Our
findings suggest that cognitive impairment in FEP is not progres-
sive after the onset of illness, but rather improves in the follow-up,
which lends support to the neurodevelopmental model of cogni-
tion. Although the effects of treatments were not analyzed in the
study, it is possible that treatment effects and/or clinical stabiliza-
tion contribute to cognitive improvements in FEP. In our sample
of FEP patients, cognitive functioning improved significantly at
the 2-year follow-up in all cognitive domains, except working
memory and executive function. Similarly, Lepage et al. (2014)
found that verbal and working memory are the cognitive domains
most affected in FEP. This suggests that specific cognitive
domains may be more sensitive than others for predicting long-
term functional outcome, that is, some may be more impaired
and may be more closely related to patient outcome.
Specifically, in our FEP sample, verbal memory predicted the
functional outcome at the 2-year follow-up. In relation to this,
Torgalsbøen et al. (2015) found that attention/vigilance and ver-
bal learning predicted remission at 6 months of follow-up,
whereas attention/vigilance and working memory predicted func-
tional outcome.
Cognitive reserve was also associated with functional out-
come. This result has also been found in other studies.
Specifically, it has been concluded that patients with a better
cognitive reserve will have better outcomes in follow-up.
Barnett et al. (2006) concluded that patients with better cogni-
tive reserve could have better reasoning skills and functional
capacity to use compensatory forms and inhibit abnormal neural
processing, which translates into greater insight and treatment
adherence. Other studies also found that cognitive reserve can
predict both the risk of illness as symptoms remit and functional
improvement (Barnett et al., 2006; Forcada et al., 2015; Grande
et al., 2017). Amoretti et al. (2016) have shown that cognitive
reserve predicts neuropsychological outcome, negative symp-
toms, and functioning at 2 years of follow-up, and hence, cogni-
tive reserve can be used as a reliable indicator for the course of
FEP patients (Amoretti et al., 2018).
The findings of our study have important implications for
clinical practice. An understanding of the association between
neurocognition, cognitive reserve, and functioning and of the
mediating role of social cognition is important for predicting
the outcome of FEP patients after illness onset. It is essential
to consider the relationship between illness outcome in patients
and their IQ, both premorbid values and changes therein, to
identify the need for a specific treatment to improve the func-
tional outcome of FEP patients. Specially, patients with lower
cognitive reserve may be more likely to need functional rehabili-
tation to help to improve their prognosis. In addition, people
with higher cognitive reserve can be oriented to more ‘normal’
work or education. Likewise, it is essential that the treatment
of these patients focuses on social cognitive deficits to improve
their functional outcome.
This study has some limitations and strengths that should be
considered. Our study had a follow-up of 2 years, and a longer
follow-up period should be considered in future research.
Another limitation is the variability across studies in how IQ is
measured. Although we used criteria based on previous studies,
there is no specific instrument validated to measure cognitive
reserve. Finally, future studies should include a control group.
The study also has important strengths. First, the results can be
considered generalizable because it is a multicenter study that
included a large sample of patients recruited in numerous
Spanish psychiatric admission centers for acute psychosis.
Second, the wide age range of the patients means that the sample
is representative of the target population, with an average age
(23.63 ± 5.9 years), lower than that for other studies with large
FEP cohorts which did not include child and adolescent patients
(OPUS trial: 26.6 ± 6.4; Bertelsen et al., 2008; and EUFEST trial:
26 ± 5.6; Kahn et al., 2008). Third, the neuropsychological battery
used was extensive and covered the areas proposed by the
NIMH-MATRICS consensus (except visual memory) (Kern
et al., 2008; Nuechterlein et al., 2008; Nuechterlein and Green,
2009).
To conclude, although further studies are required, our find-
ings suggest that cognitive reserve and neurocognition are related
to functioning, and social cognition plays a mediating role.
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